Glaxosmithkline Pharmaceuticals Dividend History

A dividend is a portion of a company's earnings distributed to its shareholders as a reward for their investment. It reflects the company's profitability and confidence in its financial health. Dividends are typically paid in cash or additional shares. At Pocketful, we make it easy for investors to track and manage dividends directly through our platform.

1. Declaration Date: The date on which the company announces its intention to pay a dividend.
2. Ex-Dividend Date: The cut-off date to determine which shareholders are eligible for the dividend. Shares purchased after this date will not qualify.
3. Record Date: The date on which the company checks its records to identify eligible shareholders.
4. Payment Date: The date on which the dividend is credited to shareholders.

Suppose Glaxosmithkline Pharmaceuticals Ltd declares a dividend of ₹5 per share on January 1, 2024. The key dates are:

• Declaration Date: January 1, 2024
• Ex-Dividend Date: January 10, 2024
• Record Date: January 11, 2024
• Payment Date: January 20, 2024

If an investor owns 100 shares of Glaxosmithkline Pharmaceuticals Ltd, they will receive ₹500 (₹5 x 100) as a dividend payment from Glaxosmithkline Pharmaceuticals Ltd. Using Pocketful, investors can easily view this data under the corporate actions section and stay updated on key announcements.

1. Cash Dividend: Paid directly to shareholders in cash.
2. Stock Dividend: Additional shares distributed instead of cash.
3. Special Dividend: A one-time dividend distributed in extraordinary circumstances.
4. Interim Dividend: Paid before the company's annual general meeting based on interim financial results.
5. Final Dividend: Declared at the end of the financial year and approved in the AGM.

Glaxosmithkline Pharmaceuticals Ltd bases its dividend decisions on profitability, cash flow availability, and long-term growth plans. A company’s dividend yield aligning with industry standards can reward investors during profitable periods. Dividend payouts are influenced by multiple factors, and companies often adjust their dividend policies based on various phases of their growth and financial strategies. Phases such as:

• Stable Phase: During stable growth years, companies offer higher dividends, reflecting surplus earnings.
• Conservative Period: In times of reinvestment or debt reduction, dividends were reduced or suspended to support strategic goals.

Dividends are a strong indicator of a company’s financial health and shareholder-friendly policies. Over the years, Glaxosmithkline Pharmaceuticals Ltd has demonstrated its commitment to rewarding shareholders through consistent dividend payouts.

1. Reward to Shareholders: Encourages long-term investment and boosts investor confidence.
2. Signal Financial Strength: Reflects profitability and financial stability.
3. Tax Advantages for Investors: Dividends may offer better tax treatment compared to capital gains in certain cases.

Tracking dividends is essential for investors who seek passive income or prefer income-generating stocks. With Pocketful, investors can access real-time data and insights on Glaxosmithkline Pharmaceuticals Ltd’s dividend payouts. At Pocketful, we simplify dividend tracking for our users:

1. Visit the stock's Corporate Actions section.
2. Look for the Dividends tab to view the declared and historical dividends.

Using the Pocketful platform, investors can:

1. View historical dividend data, including important dates such as record date, announcement date, etc.
2. Analyze dividends to compare with the industry peers.

For investors, dividends serve as both a source of passive income and a sign of financial stability. Companies like Glaxosmithkline Pharmaceuticals Ltd balance dividend payouts with growth investments, offering a mix of income and capital appreciation.

Dividends are taxable in the hands of shareholders as income from other sources. As of 2024, companies deduct a 10% TDS (Tax Deducted at Source) on dividends exceeding ₹5,000 in a financial year.